Strengthening the financial base and life sciences strategy through a capital and business alliance with ADEKA
First written in FY2018. 4 of 5 entries say "Restated". Latest entry: 2026-06-26.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「The Company has also pursued activities to generate and realize synergies from the capital and business alliance with ADEKA CORPORATION at an early stage.」
The Company continues activities aimed at generating and realizing synergies from the capital and business alliance with ADEKA. - FY2022RestatedAnnual report
「The Company has also pursued activities to generate and realize synergies from the capital and business alliance with ADEKA CORPORATION at an early stage.」
The Company continues activities aimed at generating and realizing synergies from the capital and business alliance with ADEKA. - FY2018First statedAnnual report
「ADEKA CORPORATION conducted a tender offer for the Company's shares with the aim of acquiring a majority of the Company's issued shares through a capital and business alliance, and also subscribed to a third-party allotment of new shares by the Company. The capital increase through the capital and business alliance with ADEKA CORPORATION strengthened the Company's financial base.」
Through a tender offer and a third-party allotment of new shares by ADEKA, ADEKA became the parent company in September 2018, holding 51.07% of the voting rights. The objectives are to promote strategic plans and activities relating to the life sciences businesses of both companies while maintaining the Company's autonomous and independent management.